MedPath

Octafluoropropane

Generic Name
Octafluoropropane
Brand Names
Definity, Luminity, Optison
Drug Type
Small Molecule
Chemical Formula
C3F8
CAS Number
76-19-7
Unique Ingredient Identifier
CK0N3WH0SR
Background

Perflutren, a diagnostic drug that is intended to be used for contrast enhancement during the indicated echocardiographic procedures, is comprised of lipid-coated microspheres filled with octafluoropropane(OFP) gas. When exposed to ultrasound waves, the microspheres resonate and "echo" strong signals back to the ultrasound machine. The difference in density between the gas-filled bubbles and the blood around them creates an increased level of contrast visible in the resulting ultrasound image. During echocardiography, activated Perflutren enhances images of the inner edges or borders of the heart, producing an improved image that may enable physicians to better diagnose patients.

Indication

Used as an ultrasound contrast imaging in cardiology and radiology.

Associated Conditions
-
Associated Therapies
-

Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Locally Advanced Breast Cancer-Phase II

Phase 2
Not yet recruiting
Conditions
Breast Cancer
Interventions
Drug: Definity
Device: Sonalleve Focused Ultrasound Device
First Posted Date
2023-12-29
Last Posted Date
2023-12-29
Lead Sponsor
Sunnybrook Health Sciences Centre
Target Recruit Count
200
Registration Number
NCT06185972
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

A Study of Renal Microvessel Imaging for Chronic Kidney Disease

Phase 2
Conditions
Chronic Kidney Diseases
Healthy
Interventions
Drug: Definity
Diagnostic Test: Super-resolution ultrasound imaging
First Posted Date
2023-03-10
Last Posted Date
2024-10-17
Lead Sponsor
Mayo Clinic
Target Recruit Count
186
Registration Number
NCT05764642
Locations
🇺🇸

Mayo Clinic Minnesota, Rochester, Minnesota, United States

MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer

Phase 1
Recruiting
Conditions
Melanoma
Interventions
Drug: Definity
Device: Sonalleve Focused Ultrasound Device
First Posted Date
2022-11-17
Last Posted Date
2023-12-15
Lead Sponsor
Sunnybrook Health Sciences Centre
Target Recruit Count
20
Registration Number
NCT05620290
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema

Phase 1
Completed
Conditions
Lymphedema Arm
Interventions
First Posted Date
2022-11-14
Last Posted Date
2024-08-21
Lead Sponsor
Mayo Clinic
Target Recruit Count
10
Registration Number
NCT05613946
Locations
🇺🇸

Mayo Clinic in Rochester, Rochester, Minnesota, United States

Pancreas Ultrasound Imaging in type1 Diabetes

Recruiting
Conditions
Type1diabetes
Insulitis
Pancreas Inflamed
Interventions
First Posted Date
2022-08-01
Last Posted Date
2024-09-30
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
50
Registration Number
NCT05482321
Locations
🇺🇸

University of Colorado Anschutz, Barbara Davis Center, Aurora, Colorado, United States

Diagnosing Compartment Syndrome With SHAPE vs Elastography

Phase 2
Completed
Conditions
Chronic Exertional Compartment Syndrome
Interventions
First Posted Date
2022-02-21
Last Posted Date
2023-12-12
Lead Sponsor
Thomas Jefferson University
Target Recruit Count
15
Registration Number
NCT05247541
Locations
🇺🇸

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Contrast Enhanced Ultrasound for Renal Obstruction

Phase 2
Recruiting
Conditions
Renal Obstruction
Kidney; Obstruction
Interventions
First Posted Date
2021-10-25
Last Posted Date
2025-01-08
Lead Sponsor
University of Michigan
Target Recruit Count
10
Registration Number
NCT05090800
Locations
🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Head and Neck Cancer

Phase 1
Recruiting
Conditions
Head and Neck Cancer
Interventions
Drug: DEFINITY
Device: Sonalleve Focused Ultrasound Device
First Posted Date
2020-06-16
Last Posted Date
2023-12-13
Lead Sponsor
Sunnybrook Health Sciences Centre
Target Recruit Count
20
Registration Number
NCT04431648
Locations
🇨🇦

Gregory J Czarnota, Toronto, Ontario, Canada

3-D Super Resolution Ultrasound Microvascular Imaging

Phase 2
Active, not recruiting
Conditions
Breast Cancer
Thyroid Cancer
Interventions
Drug: Definity
Device: Acoustic Angiography
First Posted Date
2019-10-23
Last Posted Date
2024-11-06
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Target Recruit Count
27
Registration Number
NCT04136912
Locations
🇺🇸

Univeristy of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States

Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound

Not Applicable
Completed
Conditions
Alzheimer Disease
Interventions
Device: Neuronavigation-guided single-element focused ultrasound transducer
Drug: Definity
Other: Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents
Other: Positron Emission Tomography (PET)
Other: Amyvid
First Posted Date
2019-10-08
Last Posted Date
2024-08-26
Lead Sponsor
Columbia University
Target Recruit Count
6
Registration Number
NCT04118764
Locations
🇺🇸

Columbia University Irving Medical Center/NYPH, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath